Recent Articles from GlobeNewswire

Presentations include real-world XPHOZAH® (tenapanor) data and new insights into hyperphosphatemia management and outcomes

AUSTIN, Texas, Oct. 05, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has entered into an amended credit agreement with its lenders, relating primarily to the principal prepayment terms and the financial covenants that would have applied during the remainder of 2026.

BRENTWOOD, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it will release its 2026 third quarter financial results after the market closes on Wednesday, November 4, 2026. A live broadcast of CoreCivic's conference call will begin at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday, November 5, 2026.

ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET

– Expands patient access to opioid-sparing pain control and advances 5x30 strategy – 

New collaboration combines Zscaler Autonomous Application Shield with Lightwell from IBM and Red Hat to help organizations reduce exposure between vulnerability disclosure and patch deployment through inline protection and validated remediation

MALVERN, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Company's Liora Monofilament Scaffold (“Liora”) product.

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, November 4, 2026. The Company will host a conference call at 1:30 PM (PT) / 4:30 PM (ET) the same day to discuss its financial results and outlook.

SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, today announced multiple contract awards totaling over $100 million to develop prototype mission applications and cyber capabilities providing space intelligence data in support of joint operations across the space and cyberspace domains.

Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular gate medicines for Lilly targets

Lease of the Liberty Magona business unit is now effective, opening a new phase for one of Italy’s historic producers of cold-rolled, galvanized and pre-painted steel

Veteran legal services executive to lead Angeion Group’s Corporate Bankruptcy Services and accelerate growth in corporate restructuring administration

WASHINGTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a new strategic partnership with the International Alliance of Psychedelic Therapy Practitioners (Psychedelic Therapy Alliance), a professional association formed in 2023 for practitioners offering psychedelic-assisted therapy in legal settings.

AssureChain, a dedicated subnet of MindChain, will run every insurance function on-chain, while MindChain provides settlement and anchoring to Ethereum

ROCHESTER, NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of deep-tech products to defense, space, and AI data centers, today announced recurring production orders for actuators in NASA's Artemis III rockets. 

Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily subcutaneous injections required by the current standard of care

STMicroelectronics announces status of common share repurchase program

LONDON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Coveron, an identity theft and scam protection service developed by Nord Security, is proud to announce that it has successfully completed SOC 2 Type II certification. Coveron concluded the audit with zero exceptions and recommendations, underlining the brand's commitment to protecting its customers' data.

BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced positive Phase 1 clinical and preclinical data for FT2109, its novel, potential best-in-class oral selective TNFR1 signaling inhibitor. The data are included in two abstracts accepted for presentation at the American College of Rheumatology (ACR) Convergence 2026, taking place November 6–11 in Orlando, Florida.

Global ISO/IEC 42001 certification underscores Altus’ commitment to delivering trusted, transparent and secure AI solutions for the CRE industry

-- Global, first-in-human study underway designed to evaluate safety, tolerability, and initial clinical efficacy of PM577a --

EMERYVILLE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the Company will host an Investor Day on Wednesday, October 21, 2026, in New York City. The live event will begin at 10:30am ET and include a Company presentation, KOL panel discussions and a live Q&A session.

Continued purchases and organic accumulation drive approximately 11% growth in SOL holdings since the Company’s August 12 Earnings Update

Mastercard to lead customer sales engagement under worldwide agreement, expanding Rezolve Ai’s distribution and subscription revenue opportunity

Registration is now open for the April 13–15 event in Orlando, featuring expanded professional development, executive and frontline leadership programs, and an exclusive Process Safety Executive Roundtable.

Appointment solidifies Cerevance’s leadership team as the company advances solengepras through Phase 3 development in Parkinson’s disease

HOUSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- VoltaGrid (the “Company”) announced the closing of the equity investments that were previously announced on May 11, 2026. In addition to the primary investment of $775 million from funds managed by Blackstone Tactical Opportunities and from Halliburton Company, the secondary investment from existing investors was upsized from $225 million to $800 million and was comprised of purchasers that included institutional and other investors.

New solution suites with embedded AI help providers, payers, and life sciences organizations turn trusted data into action

The Cosmopolitan Holy Grail Beauty Award winner marks the latest chapter in PÜR Minerals' decades-long history of creating high-performance complexion innovations recognized by the beauty industry's most trusted experts.

“Dignity Across Borders” Gala Will Honor Edgar Ramírez, Nathalie Rayes, Maria Eugenia Maury and Mary Ann Torres, While Raising Critical Funds for HIV Treatment, Migrant Integration and Earthquake Recovery in Venezuela

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (“UWM Holdings” or the “Company”) (NYSE: UWMC) on behalf of investors that purchased or otherwise acquired UWM Holdings securities between March 9, 2026 and August 5, 2026 (the “Class Period”).

Series D proceeds to support commercialization of the Zenflow Spring® System for Men with Enlarged Prostate

A new patent application covers Polyrizon’s proprietary mucoadhesive platform and its potential applications in nasal drug delivery.

GREENWICH, Conn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium carbonate, today announced the opening of a new operational office in Houston, Texas. The Houston office will serve as a project execution hub supporting operations planning as the Company advances its lithium refinery in Muskogee, Oklahoma, complementing the Company’s existing Oklahoma City office and broader corporate footprint.

- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus 40% in the placebo arm (p=0.0248); HS troponin I, a blood marker of heart muscle injury, declined more with BBP-418 than placebo (LS mean difference -17.8 ng/L; 95% CI: -35.1 to -0.5; p=0.0443)

Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), on track to initiate in the fourth quarter of 2026

35-year-old Chief Wealth Manager recognized as a California advisor to watch, following a year of significant growth and team leadership honors.

Transaction supports ownership of key cultivation and production infrastructure in Two Core Markets

SHENZHEN, China, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (NASDAQ: JZXN) today provided a comprehensive update on the latest strategic positioning and future commercial prospects of its AI smart imaging and data platform. The Company confirmed that the platform is accelerating its evolution toward a unified, modular, and scalable enterprise-grade solution, with the potential for broad commercial deployment across multiple high-value scenarios, including smart retail, intelligent security, media content management, remote inspection, and advanced driver assistance. The Company maintains its guidance of approximately US1.55 million, would represent a fundamental reshaping of its revenue structure.

Lausanne, Switzerland and Copenhagen, Denmark, Oct. 05, 2026 (GLOBE NEWSWIRE) --

ATH434 50 mg significantly slowed functional decline in MSA by approximately 52% versus placebo on the 11-item UMSARS at Week 52 with CSF NfL as a covariate 

NEW HAVEN, Conn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on October 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 157,500 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan. 

CARACAS, Venezuela, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, Monday announced the signing of two strategic agreements to accelerate the revitalization of Venezuela’s energy infrastructure across the natural gas value chain and expansion of the country’s energy production.

Company Expects to Realize Approximately $600,000 in Annualized Cost Savings

Agreement with EU-based manufacturer expands TurboGen’s defense and civilian markets and features an initial five-year term with automatic renewals to support ongoing commercial production

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Taboola.com Ltd. (“Taboola.com” or the “Company”) (NASDAQ: TBLA) on behalf of investors that purchased or otherwise acquired Taboola.com securities between May 6, 2026 and August 4, 2026 (the “Class Period”).

Alector grants Genentech exclusive rights to develop and commercialize AL050, an investigational GCase Enzyme Replacement Therapy (ERT) enabled by Alector Brain Carrier (ABC), Alector’s proprietary blood-brain barrier delivery platform

The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tumor-related hyperinsulinism and to serving these patient communities 

DV helps advertisers measure the impact of advertising in ChatGPT across the customer journey while developing brand risk and suitability pilots for conversational advertising

CEBU, Philippines, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Dmitry Shubov of Dmitry Shubov Consulting attended the Cebu Summit 2026, held October 2-3 at the Bai Hotel Cebu. The summit convened digital agency founders, automation specialists, and technical operators from across Southeast Asia and global markets to examine workflow automation, agentic deployment, and client acquisition. As Southeast Asian technology agencies and service firms increasingly integrate artificial intelligence into production environments and scale client engagements across borders, operational readiness and cross-border corporate architecture have emerged as key priorities. Participation in the summit provided direct insight into how regional agency leaders are structuring service delivery, managing cross-border commercial agreements, and addressing client data isolation requirements.

Findings highlight opportunities for further improvement in treatment use and adherence, despite the availability of multiple long-term prophylaxis and on-demand treatment options

HOUSTON and LONDON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a leader in the global chemical industry, will announce its third-quarter 2026 financial results before the U.S. market opens Friday, Oct. 30, followed by a webcast and teleconference to discuss the results at 11 a.m. EDT.Teleconference and webcast detailsFriday, Oct. 30, 202611 a.m. EDTHosted by David Dennison, head of investor relationsAccess the webcast 10 to 15 minutes prior to the start of the call at www.lyb.com/earnings.

DURHAM, N.C., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third quarter 2026 financial results before the market opens on Thursday, October 29, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.

Ramp Up on Track for Start of Commercial Production by End 2026

Public Service Announcement: Veterans First for America

Transaction in Own Shares

CALGARY, Alberta, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that it has entered into a definitive arrangement agreement to acquire Athabasca Oil Corporation (TSX: ATH) (“Athabasca”) in a cash and stock transaction with an implied enterprise value of $5.7 billion.

VAX-31 Met All Prespecified Primary Endpoints Across Age Groups Studied Compared to Prevnar 20® (PCV20) and/or Capvaxive® (PCV21)

HOUSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today that it will host a conference call to discuss its third quarter financial results on October 29, 2026, at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). The company plans to issue its third quarter 2026 earnings release and earnings presentation in advance of the call. Both will be available on KBR’s website.

INDIANAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Copper Mountain Technologies (CMT) will exhibit at European Microwave Week 2026, October 6–8 at Excel London, United Kingdom. Visit Stand K50 to explore live demonstrations and product displays highlighting solutions for RF and microwave testing, frequency extension, and integrated S-parameter measurements.

London, United Kingdom, Oct. 05, 2026 (GLOBE NEWSWIRE) -- South Street Securities Holdings Inc. (SSSHI) today announced the expansion of its UK and wider EMEA capabilities through South Street Global Ltd (SSG), a new wholly owned subsidiary. SSG has received authorisation from the UK Financial Conduct Authority (FCA) as a MiFID investment firm to conduct a range of regulated activities. Habiba Greenland has been appointed CEO of South Street Global Ltd.

Combining Gut microbiome, genetic, and glucose signals delivers unprecedented personalized care to bring clinically meaningful relief to more than half of symptomatic members

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --  Flyte Aviation, Inc. (NYSE American: VJET) (the “Company” or “Flyte”) today revealed its new corporate identity as it launches a historic new chapter in what it believes is a disruptive technology company.

Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites

BEIJING, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today provided its sales volume results for the third quarter of 2026.

Created for GODIVA’s 100th anniversary, the collaboration carries Ekrem Yalçındağ’s art from canvas into packaging, textile and the chocolate itself.

STMicroelectronics announces timing for third quarter 2026 earnings release and conference call

LIDKÖPING, Sweden, Oct. 05, 2026 (GLOBE NEWSWIRE) -- ASKO is launching a new culinary campaign together with chef Lluís de la Riva, highlighting one of today's most talked-about cooking techniques: air frying. Through a series of recipes, demonstrations and inspiring content, the campaign showcases how home cooks can achieve crisp, flavourful results using the Air Fry function built into ASKO Celsius ovens.

ISABELLE QUÉMÉNEUR IS APPOINTED AS GROUP CHIEF DIGITAL AND  INFORMATION OFFICER OF VALLOUREC AND JOINS THE EXECUTIVE COMMITTEE

Across the US and six European markets, average allocations cluster around 10% of portfolios, February's downturn made investors more likely to invest — not less — and policy signals enjoy a positive reaction 

Tulsa, Oklahoma, Oct. 04, 2026 (GLOBE NEWSWIRE) -- Elevate Holistics, a telehealth provider focused on accessible, clinician-guided wellness care, announces the launch of its online ketamine telehealth platform, offering eligible patients a structured approach to low-dose ketamine treatment from home. The company has years of experience in the alternative medicine space and has helped more than 100,000 patients navigate the process of obtaining legal access to medical cannabis. The platform combines virtual provider evaluations, behavioral health support, ongoing monitoring, and at-home medication fulfillment through licensed pharmacy services.

The company has presented updated data from the LUCE-1 Phase 1/2 study in Usher syndrome type 1B and preclinical data supporting the clinical translation of AAVB-039 in Stargardt disease

Company highlights its focus on AI applications in education, plans a year-round showcase at its Las Vegas venue, and reaffirms its disclosure practices

SAN CARLOS, Calif., Oct. 04, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced it will host a webcast and conference call tomorrow, October 5, 2026 at 8:00 a.m. ET / 5:00 a.m. PT to present topline data from the OPUS-1 adult pivotal Phase 3 trial evaluating the safety, tolerability and immunogenicity of VAX-31, the Company’s 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD) and pneumococcal pneumonia.